Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 On 16thDecember 2014
Summary The industry analysis specialist, has released its new report, “Gallbladder Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Gallbladder Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Gallbladder Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Gallbladder Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-gallbladder-cancer-therapeutics-pipeline-assessment-and-marketforecasts-135233 Scope The report provides information on the key drivers and challenges of the Gallbladder Cancer Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Gallbladder Cancer Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Gallbladder Cancer Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Gallbladder Cancer Therapeutics market. - Analysis of key recent licensing and partnership agreements in Gallbladder Cancer Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Gallbladder Cancer Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Gallbladder Cancer Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Gallbladder Cancer Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Gallbladder Cancer Therapeutics - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.4 Pathophysiology 2.5 Signs and Symptoms 2.6 Diagnosis 2.6.1 Physical exam and history 2.6.2 Ultrasound exam 2.6.3 Liver function tests 2.6.4 Carcinoembryonic antigen (CEA) assay 2.6.5 Cancer antigen 19-9 (CA 19-9) assay 2.6.6 CT scan (CAT scan) 2.6.7 Blood chemistry studies 2.6.8 Chest x-ray 2.6.9 MRI (magnetic resonance imaging) 2.6.10 ERCP (Endoscopic Retrograde Cholangiopancreatography) 2.6.11 Biopsy Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.6.12 Laparoscopy 2.6.13 PTC (Percutaneous Transhepatic Cholangiography) 2.7 Staging 2.7.1 TNM Classification 2.7.2 Treatment Options Based on the Extent of Cancer 2.8 Treatment 2.8.1 Surgery 2.8.2 Chemotherapy 2.8.3 Radiation therapy (RT) 2.9 Chemotherapy Regimens 2.10 GlobalData Pipeline Report Guidance 3 Gallbladder Cancer Therapeutics - Market Characterization 3.1 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Global 3.2 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Global 3.3 Gallbladder Cancer Therapeutics Market Size (2005-2010) - US 3.4 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - The US 3.5 Gallbladder Cancer Therapeutics Market Size (2005-2010) - The UK 3.6 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - The UK 3.7 Gallbladder Cancer Therapeutics Market Size (2005-2010) - France 3.8 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - France 3.9 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Germany 3.10 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Germany 3.11 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Italy 3.12 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Italy 3.13 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Spain 3.14 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Spain 3.15 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Japan 3.16 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Japan 3.17 Drivers and Barriers for the Gallbladder Cancer Therapeutics Market 3.17.1 Drivers for the Gallbladder Cancer Therapeutics Market 3.17.2 Barriers for the Gallbladder Cancer Therapeutics Market 3.18 Key Events Impacting the Future Market 3.18.1 Opportunity and Unmet Need 3.19 Key Takeaway 4 Gallbladder Cancer Therapeutics Market - Competitive Assessment 4.1 Overview 4.1.1 Strategic Competitor Assessment 4.2 Profiles of the Commonly Used Products in the Gallbladder Cancer Therapeutics Market 4.2.1 Gemcitabine Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
4.2.2 Gemcitabine and Cisplatin 4.2.3 Gemcitabine and Oxaliplatin (GEMOX) 4.2.4 Gemcitabine and Capecitabine 4.2.5 5-Fluorouracil (5-FU) and Cisplatin 4.3 Key Takeaway 5 Gallbladder Cancer Therapeutics Market - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Gallbladder Cancer Pipeline Analysis - Pipeline by Clinical Phases of Development 5.3.1 Gallbladder Cancer Therapeutics - Phase II Pipeline 5.3.2 Gallbladder Cancer Therapeutics - Phase I/II Pipeline 5.3.3 Gallbladder Cancer Therapeutics - Phase I Pipeline 5.4 Gallbladder Cancer Pipeline by Mechanism of Action 5.5 Gallbladder Cancer Technology Trends Analytical Framework 5.6 Profiles of Phase II Drugs under Clinical Development 5.6.1 Caprelsa (vandetanib) 5.6.2 Sinofuan (fluorouracil implant) 5.7 Key Takeaway 6 Gallbladder Cancer Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Country (US, EU5 and Japan) 6.2 Clinical Trials Mapping by Phase 6.3 Clinical Trials Mapping by Trial Status 6.4 Overall Sponsors 6.5 Prominent Sponsors 6.6 Top Companies Participating in Gallbladder Cancer Therapeutics Clinical Trials 7 Gallbladder Cancer Therapeutics - Strategic Assessment 7.1 Future Market Competition Scenario 8 Gallbladder Cancer Therapeutics - Future Players in The Market 8.1 Introduction 8.2 Company Profiles 8.2.1 AstraZeneca PLC 8.2.2 Simcere Pharmaceutical Co. Ltd. 9 Gallbladder Cancer Therapeutics- Appendix 9.1 Definitions 9.2 Acronyms 9.3 Research Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: Survival Rates of Gallbladder Cancer in Various Stages Table 2: Prevalence of Gallbladder Cancer in Major Markets Table 3: Gallbladder Cancer, TNM Definitions Table 4: Gallbladder Cancer, Stage Grouping Table 5: Treatment Options Based on the Extent of Cancer Table 6: Gallbladder Cancer Chemotherapy regimens Table 7: Gallbladder Cancer Therapeutics Market, Global, Revenue ($m), 2005-2010 Table 8: Gallbladder Cancer Therapeutics Market, Global, Forecast ($m), 2010-2018 Table 9: Gallbladder Cancer Therapeutics Market, The US, Revenue ($m), 2005-2010 Table 10: Gallbladder Cancer Therapeutics Market, The US, Revenue ($m), 2010-2018 Table 11: Gallbladder Cancer Therapeutics Market, The UK, Revenue ($m), 2005-2010 Table 12: Gallbladder Cancer Therapeutics Market, The UK, Forecast ($m), 2010-2018 Table 13: Gallbladder Cancer Therapeutics Market, France, Revenue ($m), 2005-2010 Table 14: Gallbladder Cancer Therapeutics Market, France, Forecast ($m), 2010-2018 Table 15: Gallbladder Cancer Therapeutics Market, Germany, Revenue ($m), 2005-2010 Table 16: Gallbladder Cancer Therapeutics Market, Germany, Forecast ($m), 2010-2018 Table 17: Gallbladder Cancer Therapeutics Market, Italy, Revenue ($m), 2005-2010 Table 18: Gallbladder Cancer Therapeutics Market, Italy, Forecast ($m), 2010-2018 Table 19: Gallbladder Cancer Therapeutics Market, Spain, Revenue ($m), 2005-2010 Table 20: Gallbladder Cancer Therapeutics Market, Spain, Forecast ($m), 2010-2018 Table 21: Gallbladder Cancer Therapeutics Market, Japan, Revenue ($m), 2005-2010 Table 22: Gallbladder Cancer Therapeutics Market, Japan, Forecast ($m), 2010-2018 Table 23: Gallbladder Cancer - Phase II Pipeline Table 24: Gallbladder Cancer Therapeutics - Phase I/II Pipeline Table 25: Gallbladder Cancer Therapeutics - Phase I Pipeline Table 26: Gallbladder Cancer Therapeutics - Clinical Trials by Country, 2011 Table 27: Gallbladder Cancer Therapeutics - Clinical Trials by Phase, 2011 Table 28: Gallbladder Cancer Therapeutics - Clinical Trials by Status, 2011 Table 29: Gallbladder Cancer Therapeutics - Clinical Trials, by Overall Sponsors, 2011 Table 30: Gallbladder Cancer Therapeutics - Clinical Trials by Prominent Sponsors, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 31: Gallbladder Cancer Therapeutics Clinical Trial - Company Sponsors by Phase, 2011 Table 32: AstraZeneca - Gallbladder Cancer Pipeline Table 33: Simcere Pharmaceutical - Gallbladder Cancer Pipeline
List Of Figures Figure 1: Anatomy of the Gallbladder Figure 2: Magnetic Resonance Imaging Figure 3: Gallbladder Cancer Therapeutics Market, Global, Revenue ($m), 2005-2010 Figure 4: Gallbladder Cancer Therapeutics, Market Share ($m), 2010 Figure 5: Gallbladder Cancer Therapeutics Market, Global, Forecast ($m), 2010-2018 Figure 6: Gallbladder Cancer Therapeutics, Market Share ($m), 2018 Figure 7: Gallbladder Cancer Therapeutics Market, The US, Revenue ($m), 2005-2010 Figure 8: Gallbladder Cancer Therapeutics Market, The US, Forecast ($m), 2010-2018 Figure 9: Gallbladder Cancer Therapeutics Market, The UK, Revenue ($m), 2005-2010 Figure 10: Gallbladder Cancer Therapeutics, The UK, Forecast ($m), 2010-2018 Figure 11: Gallbladder Cancer Therapeutics Market, France, Revenue ($m), 2005-2010 Figure 12: Gallbladder Cancer Therapeutics Market, France, Forecast ($m), 2010-2018 Figure 13: Gallbladder Cancer Therapeutics Market, Germany, Revenue ($m), 2005-2010 Figure 14: Gallbladder Cancer Therapeutics Market, Germany, Forecast ($m), 2010-2018 Figure 15: Gallbladder Cancer Therapeutics Market, Italy, Revenue ($m), 2005-2010 Figure 16: Gallbladder Cancer Therapeutics Market, Italy, Forecast ($m), 2010-2018 Figure 17: Gallbladder Cancer Therapeutics Market, Spain, Revenue ($m), 2005-2010 Figure 18: Gallbladder Cancer Therapeutics Market, Spain, Forecast ($m), 2010-2018 Figure 19: Gallbladder Cancer Therapeutics Market, Japan, Revenue ($m), 2005-2010 Figure 20: Gallbladder Cancer Therapeutics Market, Japan, Forecast ($m), 2010-2018 Figure 21: Gallbladder Cancer Therapeutics, Key Events Impacting the Future Market Figure 22: Opportunity and Unmet Need in the Gallbladder Cancer Therapeutics Market, 2011 Figure 23: Gallbladder Cancer Therapeutics Market- Strategic Competitor Assessment, 2011 Figure 24: Gallbladder Cancer Therapeutics - Pipeline by Phase of Clinical Development, 2011 Figure 25: Gallbladder Cancer Therapeutics - Clinical Pipeline by Mechanism Of Action, 2011 Figure 26: Gallbladder Cancer Therapeutics - Technology Trends Analytical Framework, 2011 Figure 27: Gallbladder Cancer Therapeutics - Technology Trends Analytical Framework Description, 2011 Figure 28: Gallbladder Cancer Therapeutics - Clinical Trials by Country, 2011 Figure 29: Gallbladder Cancer Therapeutics - Clinical Trials by Phase, 2011 Figure 30: Gallbladder Cancer Therapeutics - Clinical Trials by Status, 2011 Figure 31: Gallbladder Cancer Therapeutics - Clinical Trials by Overall Sponsors, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 32: Gallbladder Cancer Therapeutics - Clinical trials by Prominent Sponsors, 2011 Figure 33: Gallbladder Cancer Therapeutics Clinical Trial - Company Sponsors by Phase, 2011 Figure 34: Gallbladder Cancer Therapeutics, Strategic Assessment, 2011 Figure 35: Gallbladder Cancer Therapeutics Market - Clinical Pipeline by Company , 2011 Figure 36: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 http://www.jsbmarketresearch.com/healthcare-medical/r-gallbladder-cancertherapeutics-pipeline-assessment-and-market-forecasts-135233
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/